Data / Form D filings / Angiex, Inc.
Angiex, Inc.: Form D filings
Angiex, Inc., a biotechnology company in Cambridge, MA, filed 3 Form D notices with the SEC between 2017 and 2025. The latest, on September 26, 2025, reports $22 million sold of a $28.4 million offering to 137 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 150 Cambridge Park Drive, 5th Floor, Cambridge, MA, 02140
- Phone
- (857) 203-7808
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1710380
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 26, 2025 | Amendment | $28,409,510 | $21,991,695 | $6,417,815 | 137 | Jul 31, 2025 | sec.gov |
| Aug 14, 2025 | New notice | $20,284,497 | $10,980,030 | $9,304,467 | 57 | Jul 31, 2025 | sec.gov |
| Jul 17, 2017 | New notice | $3,000,022 | $2,880,022 | $120,000 | 3 | Jul 3, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jonathan Adams | Director | |
| Errik Anderson | Director | |
| Jason Camm | Director | |
| Fabian Hansen | Director | |
| Paul Jaminet | Executive Officer, Director | |
| Amal Amin | Director | |
| Haijing Guo | Director | |
| Iain Dukes | Director | |
| Tina Neel | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Sep 22, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Angiex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.